Abstract
Background: The global resurgence of Mpox has emerged as a significant public health issue, with cases identified in over 116 countries by 2024. This study leverages joinpoint regression and ARIMA forecasting models to analyze Mpox trends and project future outbreaks, underscoring the need for adaptable public health responses due to varied virulence across strains.
Methods: Using joinpoint regression, we analyzed changes in Mpox case trends from January 1 to September 15, 2024, and employed ARIMA models to forecast future outbreaks in the ten most affected countries for next ten weeks.
Results: The analysis revealed significant fluctuations in Mpox cases, particularly in the United States and the Democratic Republic of Congo (DRC). Joinpoint regression detected crucial shifts in epidemic trends, while ARIMA models forecasted short-term and long-term trajectories. By October 24, 2024, Spain is predicted to report the highest new cases at 21, followed by the DRC with 9. France and Germany are expected to see 7 new cases each. In contrast, Brazil, Colombia, the UK, and the US might report only 1 new case, with no new cases expected in Mexico and Peru. The UK and US are projected to have the highest cumulative cases at 240,119 and 239,976, respectively, with Brazil and the DRC following with 87,405 and 61,867 cases.
Conclusion: This study highlights the importance of advanced modeling in predicting Mpox outbreaks and guiding tailored public health strategies. These forecasts are crucial for improving preparedness and response efforts against Mpox and other infectious diseases.
Keywords:
Gender disparities, survival rates, HPV, head and neck cancer, systematic review, meta-analysisReferences
1. Memariani M, Memariani H. Global Re-emergence of Monkeypox: A Synoptic Review. Ibnosina Journal of Medicine and Biomedical Sciences. 2024;16(02): 049-056.
2. Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe J-J, Marks M, et al. Monkeypox. The Lancet. 2023;401(10370):60-74.
3. Anil S, Joseph B, Thomas M, Sweety VK, Suresh N, Waltimo T. Monkeypox: A Viral Zoonotic Disease of Rising Global Concern. Infectious Diseases & Immunity. 2024;4(03):121-31.
4. Andrei G, Snoeck R. Differences in pathogenicity among the Mpox virus clades: impact on drug discovery and vaccine development. Trends in Pharmacological Sciences. 2023;44(10):719-739.
5. Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, et al. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo. Emerging infectious diseases. 2016;22(6):1014.
6. Kraemer MU, Tegally H, Pigott DM, Dasgupta A, Sheldon J, Wilkinson E, et al. Tracking the 2022 monkeypox outbreak with epidemiological data in real-time. The Lancet Infectious Diseases. 2022;22(7):941-2.
7. Acosta-Espana JD, Bonilla-Aldana DK, Luna C, Rodriguez-Morales AJ. The Resurgence of Mpox: A New Global Health Crisis. Infez Med. 2024;32(3):267-71.
8. Organization WH. WHO Director-General declares Mpox outbreak a public health emergency of international concern [Internet]. 2024. [cited on 2024 Dec 17]. Available from: https://www.who.int/news/item/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern
9. Acharya A, Kumar N, Singh K, Byrareddy SN. Mpox in MSM: Tackling Stigma, Minimizing Risk Factors, Exploring Pathogenesis, and Treatment Approaches. Biomedical Journal. 2024:100746.
10. Anderer S. WHO Announces Mpox Global Plan, Appeals for Funding. JAMA. 2024;332(15):1228
11. Cordeiro R, Caetano CP, Sobral D, Ferreira R, Coelho L, Pelerito A, et al. Viral genetics and transmission dynamics in the second wave of Mpox outbreak in Portugal and forecasting public health scenarios. Emerg Microbes Infect. 2024;13(1):2412635.
12. WHO. 2022-23 Mpox (Monkeypox) Outbreak: Global Trends. World Health Organization. 2023.
13. Anwar F, Haq I, Ahmad R, Shahab M, Ullah A, Tong Y. Monkeypox: A Timely Update on the Global Outbreak, Transmission, Viral Replication, Vaccination and Clinical Strategies. Supramolecular Materials. 2024:100071.
14. Sheek-Hussein M, Alsuwaidi AR, Davies EA, Abu-Zidan FM. Monkeypox: A current emergency global health threat. Turkish Journal of Emergency Medicine. 2023;23(1):5-16.
15. Nachega JB, Sam-Agudu NA, Ogoina D, Mbala-Kingebeni P, Ntoumi F, Nakouné E, et al. The surge of Mpox in Africa: a call for action. The Lancet Global Health. 2024.
16. Soto-Ferrari M, Carrasco-Pena A, Prieto D. Deep Learning Architectures Framework for Emerging Outbreak Forecasting of Mpox: A Bagged Ensemble Scheme to Model Accurate Prediction Intervals. 2023.
17. Charniga K, Madewell ZJ, Masters NB, Asher J, Nakazawa Y, Spicknall IH. Nowcasting and forecasting the 2022 US Mpox outbreak: support for public health decision making and lessons learned. Epidemics. 2024;47:100755.
18. Pramanik A, Sultana S, Rahman MS, editors. Time series analysis and forecasting of Monkeypox disease using ARIMA and SARIMA model. 2022 13th International Conference on Computing Communication and Networking Technologies (ICCCNT); 2022: IEEE.
19. Zhang L, Huang J, Yan W, Zhao Y, Wang D, Chen B. Global prediction for Mpox epidemic. Environmental Research. 2024;243:117748.
20. Collins OC, Duffy KJ. Dynamics and control of Mpox disease using two modelling approaches. Modeling Earth Systems and Environment. 2024;10(2):1657-69.
21. Abdelaziz M, Ahmed A, Riad A, Abderrezak G, Djida AA. Forecasting daily confirmed COVID-19 cases in Algeria using ARIMA models. East Mediterr Health J. 2023;29(7):515-9.
22. Munir T, Khan M, Cheema SA, Khan F, Usmani A, Nazir M. Time series analysis and short-term forecasting of monkeypox outbreak trends in the 10 major affected countries. BMC Infect Dis. 2024;24(1):16.
23. Zhang L, Huang J, Chen B, Zhao Y, Wang D, Yan W. Global prediction for monkeypox epidemic. medRxiv. 2022:2022.10. 21.22280978.
24. Akinola S, Wang Q, Olukanmi P, Marwala T. Early prediction of monkeypox virus outbreak using machine learning. IETI Trans Data Anal Forecast. 2023;1(2):14-29.
25. Wei F, Peng Z, Jin Z, Wang J, Xu X, Zhang X, et al. Study and prediction of the 2022 global monkeypox epidemic. Journal of biosafety and biosecurity. 2022;4(2):158-62.
26. Bleichrodt A, Luo R, Kirpich A, Chowell G. Evaluating the forecasting performance of ensemble sub-epidemic frameworks and other time series models for the 2022–2023 Mpox epidemic. Royal Society Open Science. 2024;11(7):240248.
27. Bleichrodt A, Dahal S, Maloney K, Casanova L, Luo R, Chowell G. Real-time forecasting the trajectory of monkeypox outbreaks at the national and global levels, July–October 2022. BMC medicine. 2023;21(1):19.
28. Munir T, Khan M, Cheema SA, Khan F, Usmani A, Nazir M. Time series analysis and short-term forecasting of monkeypox outbreak trends in the 10 major affected countries. BMC Infectious Diseases. 2024;24(1):16.
29. Bleichrodt A, Luo R, Kirpich A, Chowell G. Retrospective evaluation of short-term forecast performance of ensemble sub-epidemic frameworks and other time-series models: The 2022-2023 Mpox outbreak across multiple geographical scales, July 14th, 2022, through February 26th, 2023. medRxiv. 2023.
30. Marín-Sánchez O, Pesantes-Grados P, Pérez-Timaná L, Marín-Machuca O, Sánchez-Llatas CJ, Chacón RD. Comparative epidemiological assessment of monkeypox infections on a global and continental scale using logistic and gompertz mathematical models. Vaccines. 2023;11(12):1765.
31. Rana J, Patel SK, Agrawal A, Channabasappa NK, Niranjan AK, Das BC, et al. Mpox vaccination in global perspective: Priorities and challenges. Annals of Medicine and Surgery. 2023;85(5):2243-6.
32. Jafari K, Woodward GA. Mpox. Pediatric Emergency Care. 2023;39(11):883-9.
33. Allan-Blitz L-T, Gandhi M, Adamson P, Park I, Bolan G, Klausner JD. A position statement on Mpox as a sexually transmitted disease. Clinical Infectious Diseases. 2023;76(8):1508-12.
34. Karki R, Gadiya Y, Zaliani A, Gribbon P. Mpox Knowledge Graph: a comprehensive representation embedding chemical entities and associated biology of Mpox. Bioinformatics Advances. 2023;3(1):vbad045.
35. McLean J, Gunaratne S, Zucker J. Update on Mpox: What the Primary Care Clinician Should Know. Medical Clinics. 2024;108(2):355-71.
How to Cite
License
Copyright (c) 2025 Aroop Mohanty, Priyadarshini. P, Sowntappan Balasubramanian , Santenna Chenchula, Ranjit Sah
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright© by the author(s). Published by the Evidence Journals. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Similar Articles
- Senthil Thirusangu, Janet Prameela Dsouza, Sumana Mukhopadhyay , Abdullahi Saminu , Tathagata jha, Prabhat, Aroop Mohanty, Revolutionizing antiviral therapies: the promise of nucleic acid-based interventions , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Senthil Thirusangu, Janet Prameela Dsouza, Sumana Mukhopadhyay , Abdullahi Saminu , Tathagata jha, Prabhat, Aroop Mohanty, Revolutionizing antiviral therapies: the promise of nucleic acid-based interventions , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Mona Thangamma AG , Shree Rath, Andria J N Sirur , Vijaya kumar Uthakalla, Santenna Chenchula , Swati Misra, Tuhin James Paulo , Debopriya, Chanchal Goyal , Ujjawal Sharma , G Vinod , Firdaus Samad, Arindam Biswas , Sree Sudha T Y, Cost Effectiveness of Fruquintinib for Colorectal Cancer: A systematic review , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Prasanna Srinivasan Ramalingam , Rajashekar Rao Barkur, Manjisa Choudhury, Priyanka Singla, Pavan Kumar , Prabhat, Ranjit Sah, Advancing genomic frontiers: emerging trends and transformative technologies in next-generation sequencing and computational analysis , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
